These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23708439)

  • 1. e-Prescribing: characterisation of patient safety hazards in community pharmacies using a sociotechnical systems approach.
    Odukoya OK; Chui MA
    BMJ Qual Saf; 2013 Oct; 22(10):816-25. PubMed ID: 23708439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators to recovering from e-prescribing errors in community pharmacies.
    Odukoya OK; Stone JA; Chui MA
    J Am Pharm Assoc (2003); 2015; 55(1):52-8. PubMed ID: 25539495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retail pharmacy staff perceptions of design strengths and weaknesses of electronic prescribing.
    Odukoya O; Chui MA
    J Am Med Inform Assoc; 2012; 19(6):1059-65. PubMed ID: 22753809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-prescribing errors in community pharmacies: exploring consequences and contributing factors.
    Odukoya OK; Stone JA; Chui MA
    Int J Med Inform; 2014 Jun; 83(6):427-37. PubMed ID: 24657055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do community pharmacies recover from e-prescription errors?
    Odukoya OK; Stone JA; Chui MA
    Res Social Adm Pharm; 2014; 10(6):837-852. PubMed ID: 24373898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between e-prescriptions and community pharmacy workflow.
    Odukoya OK; Chui MA
    J Am Pharm Assoc (2003); 2012; 52(6):e168-74. PubMed ID: 23229979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Think Aloud Protocols to Assess E-Prescribing in Community Pharmacies.
    Odukoya OK; Chui MA
    Innov Pharm; 2012; 3(3):88. PubMed ID: 24860689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of e-prescribing in chain community pharmacy: best-practice recommendations.
    Rupp MT; Warholak TL
    J Am Pharm Assoc (2003); 2008; 48(3):364-70. PubMed ID: 18595821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruptions in community pharmacies: Frequency, sources, and mitigation strategies.
    Reddy A; Abebe E; Rivera AJ; Stone JA; Chui MA
    Res Social Adm Pharm; 2019 Oct; 15(10):1243-1250. PubMed ID: 30420227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hidden Role of Community Pharmacy Technicians in Ensuring Patient Safety with the Use of E-Prescribing.
    Odukoya OK; Schleiden LJ; Chui MA
    Pharmacy (Basel); 2015 Dec; 3(4):330-343. PubMed ID: 27525221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality and Variability of Patient Directions in Electronic Prescriptions in the Ambulatory Care Setting.
    Yang Y; Ward-Charlerie S; Dhavle AA; Rupp MT; Green J
    J Manag Care Spec Pharm; 2018 Jul; 24(7):691-699. PubMed ID: 29345553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handing Off Electronic Prescription Data From Prescribers to Community Pharmacies: A Qualitative Analysis of Pharmacy Staff Perspectives.
    Whitaker M; Lester C; Rowell B
    J Patient Saf; 2024 Sep; 20(6):397-403. PubMed ID: 38742931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic prescription as a driver for digitalization in Finnish pharmacies.
    Peltoniemi T; Suomi R; Peura S; Lähteenoja MNY
    BMC Health Serv Res; 2021 Sep; 21(1):1017. PubMed ID: 34565354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-prescribing: a focused review and new approach to addressing safety in pharmacies and primary care.
    Odukoya OK; Chui MA
    Res Social Adm Pharm; 2013; 9(6):996-1003. PubMed ID: 23062769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of ambulatory prescriptions in Taiwan: translating claims data into initiatives.
    Ho YF; Hsieh LL; Lu WC; Hu FC; Hale KM; Lee SJ; Lin FJ
    Int J Clin Pharm; 2012 Feb; 34(1):72-80. PubMed ID: 22138781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CancelRx case study: implications for clinic and community pharmacy work systems.
    Watterson TL; Stone JA; Kleinschmidt PC; Chui MA
    BMC Health Serv Res; 2023 Dec; 23(1):1360. PubMed ID: 38057835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmitting and processing electronic prescriptions: experiences of physician practices and pharmacies.
    Grossman JM; Cross DA; Boukus ER; Cohen GR
    J Am Med Inform Assoc; 2012; 19(3):353-9. PubMed ID: 22101907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
    Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
    Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of electronic prescriptions on medication safety in Finnish community pharmacies: A survey of pharmacists.
    Kauppinen H; Ahonen R; Timonen J
    Int J Med Inform; 2017 Apr; 100():56-62. PubMed ID: 28241938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.